Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: An overview of FMD PART 06: Market landscape • Market overview • Five forces analysis PART 07: Market segmentation by product type • Conventional vaccines • Emergency vaccines PART 08: Market segmentation by application • Cattle • Pigs • Sheep and goats • Others PART 09: Geographical segmentation • FMD vaccines market in APAC • FMD vaccines market in EMEA • FMD vaccines market in Americas PART 10: Decision framework • PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Increase in inorganic growth strategies • Advancements in technology • Increasing preventive measures in FMD-free areas PART 13: Vendor landscape • Competitive scenario PART 14: Key vendor analysis • Biogénesis Bagó • Boehringer Ingelheim • Brilliant Bio Pharma • Indian Immunologicals • Merck • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global FMD vaccines market snapshot Exhibit 02: Global FMD vaccines market 2016-2021 ($ millions) Exhibit 03: Opportunity analysis in global FMD vaccines market Exhibit 04: Five forces analysis Exhibit 05: Global FMD vaccines market segmentation by vaccine type 2016 Exhibit 06: Global conventional FMD vaccines market 2016-2021 ($ millions) Exhibit 07: Global emergency FMD vaccines market 2016-2021 ($ millions) Exhibit 08: Global FMD vaccines market segmentation by application 2016 Exhibit 09: Segmentation of global FMD vaccines market based on geography 2016 and 2021 Exhibit 10: FMD vaccines market revenue by geography 2016-2021 ($ millions) Exhibit 11: Key countries with FMD occurrence Exhibit 12: Market scenario in APAC Exhibit 13: FMD vaccines market in APAC 2016-2021 ($ millions) Exhibit 14: Key FMD outbreaks in Asian countries Exhibit 15: Market scenario in EMEA Exhibit 16: FMD vaccines market in EMEA 2016-2021 ($ millions) Exhibit 17: Market scenario in Americas Exhibit 18: FMD vaccines market in Americas 2016-2021 ($ millions) Exhibit 19: Impact of drivers Exhibit 20: Impact of challenges Exhibit 21: Competitive structure analysis of global FMD vaccines market 2016 Exhibit 22: Competitive analysis of global FMD vaccines market Exhibit 23: Strategic success factors of companies in global FMD vaccines market Exhibit 24: Biogénesis Bagó: Key highlights Exhibit 25: Biogénesis Bagó: Strength assessment Exhibit 26: Biogénesis Bagó: Strategy assessment Exhibit 27: Biogénesis Bagó: Opportunity assessment Exhibit 28: Boehringer Ingelheim: Key highlights Exhibit 29: Boehringer Ingelheim: Strength assessment Exhibit 30: Boehringer Ingelheim: Strategy assessment Exhibit 31: Boehringer Ingelheim: Opportunity assessment Exhibit 32: Brilliant Bio Pharma: Strength assessment Exhibit 33: Brilliant Bio Pharma: Strategy assessment Exhibit 34: Brilliant Bio Pharma: Opportunity assessment Exhibit 35: Indian Immunologicals: Key highlights Exhibit 36: Indian Immunologicals: Strength assessment Exhibit 37: Indian Immunologicals: Strategy assessment Exhibit 38: Indian Immunologicals: Opportunity assessment Exhibit 39: Merck: Key highlights Exhibit 40: Merck: Strength assessment Exhibit 41: Merck: Strategy assessment Exhibit 42: Merck: Opportunity assessment

Merck, Brilliant Bio Pharma, Indian Imumunologicals, Biogénesis Bagó, Boehringer Ingelheim, Bayer HealthCare, Ceva, Inovio Pharmaceuticals, Plumbline Life Sciences, and SEPPIC.